SynthesisFrontiers in oncology2020

Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis.

Konstantinos Christofyllakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.